FDA Grants 510(k) Clearance for AI Detection and Triage of Cervical Spine Fractures
The CINA-CSpine AI software reportedly demonstrated a 90.3 percent sensitivity rate for cervical spine fractures in validation testing on more than 300 non-contrast CT scans.
The CINA-CSpine artificial intelligence (AI) software has garnered 510(k) clearance from the Food and Drug Administration (FDA) for the detection and triage of cervical spine fractures on computed tomography (CT) scans.
Facilitating timely treatment of cervical spine fractures, the CINA-CSpine software provides automated flagging of suspected acute fractures and subsequent alerts to reviewing radiologists, according to Avicenna.AI, the developer of the software.
In validation testing involving over 300 CT scans acquired from 36 scanner models and five different vendors, the company said the newly FDA-cleared CINA-CSpine software demonstrated a 90.3 percent sensitivity for cervical spine fractures. (Photo courtesy of Avicenna.AI .)
In validation testing involving over 300 CT scans acquired from 36 scanner models and five different vendors, the company said the CINA-CSpine software demonstrated a 90.3 percent sensitivity rate and a 91.9 percent specificity rate for cervical spine fractures.
"These results demonstrate that our CINA-CSpine algorithm is capable of providing prompt and accurate findings that could positively guide physicians towards better assessments and improved patient outcomes," added Cyril Di Grandi, the co-founder and chief executive officer of Avicenna.ai.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
